Literature DB >> 15139516

Molecular reactivity of busulfan through its experimental electrostatic properties in the solid state.

Nour Eddine Ghermani1, Anne Spasojević-de Biré, Nouzha Bouhmaida, Souad Ouharzoune, Jérôme Bouligand, Anne Layre, Ruxandra Gref, Patrick Couvreur.   

Abstract

PURPOSE: In the route of developing novel liquid phase formulations based on the encapsulation of busulfan into liposomes in nontoxic solvents, drug crystallization inevitably occurs. In order to better understand the reactivity of busulfan, the characterization of its molecular properties was therefore considered as a key point. Also, preliminary attempts to prevent crystallization using cyclodextrins were explored.
METHODS: An accurate single-crystal high-resolution X-ray diffraction experiment at 100 K has been carried out. The experimental electron density of busulfan was refined using a multipole model. Busulfan/beta-cyclodextrin coprecipitates were analyzed by powder X-ray diffraction and 1H-NMR spectroscopy.
RESULTS: The electrostatic properties of busulfan and the methylsulfonate fragment dipole moment (3.2 D) were determined. The polar moieties play a key role in the crystallization of busulfan, which presents a nucleophilic region surrounding the sulfonate part, whereas the carbon chain displays an electrophilic character. This highlights the subtle busulfan/beta-cyclodextrin association.
CONCLUSIONS: Busulfan electrostatic properties were used to quantify its chemical reactivity. This explains the difficulty to formulate busulfan into liposomes due to a strong polar character of the methylsulfonate terminal groups. The complexation with cyclodextrins deserves to be further investigated to allow the formulation of busulfan in nontoxic solvents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15139516     DOI: 10.1023/b:pham.0000022406.04888.f1

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Molecular fragment electric moments derived from the fit of the experimental electrostatic potential. Application to the water molecule.

Authors: 
Journal:  Acta Crystallogr A       Date:  1999-07-01       Impact factor: 2.290

2.  Introduction and General Overview of Cyclodextrin Chemistry.

Authors:  József Szejtli
Journal:  Chem Rev       Date:  1998-07-30       Impact factor: 60.622

3.  The Cambridge Structural Database: a quarter of a million crystal structures and rising.

Authors:  Frank H Allen
Journal:  Acta Crystallogr B       Date:  2002-05-29

4.  Reproducability and transferability of topological properties; experimental charge density of the hexapeptide cyclo-(D,L-Pro)2-(L-Ala)4 monohydrate.

Authors:  B Dittrich; T Koritsánszky; M Grosche; W Scherer; R Flaig; A Wagner; H G Krane; H Kessler; C Riemer; A M M Schreurs; P Luger
Journal:  Acta Crystallogr B       Date:  2002-07-30

5.  Myleran in chronic myeloid leukaemia; results of treatment.

Authors:  D A GALTON
Journal:  Lancet       Date:  1953-01-31       Impact factor: 79.321

Review 6.  The veno-occlusive disease of the liver.

Authors:  F Baron; M Deprez; Y Beguin
Journal:  Haematologica       Date:  1997 Nov-Dec       Impact factor: 9.941

7.  A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation.

Authors:  E Olavarria; M Hassan; A Eades; C Nilsson; A Timms; J Matthews; C Craddock; E Kanfer; J Apperley; J Goldman
Journal:  Leukemia       Date:  2000-11       Impact factor: 11.528

8.  Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation.

Authors:  L B Grochow; R J Jones; R B Brundrett; H G Braine; T L Chen; R Saral; G W Santos; O M Colvin
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

9.  Structures of three DNA cross-linking agents, ethane-1,2-di(methylsulfonate), propane-1,3-di(methylsulfonate) and n-butane-1,4-di(methylsulfonate).

Authors:  R McKenna; S Neidle; R Kuroda; B W Fox
Journal:  Acta Crystallogr C       Date:  1989-02-15       Impact factor: 1.172

10.  Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation.

Authors:  G Vassal; S Koscielny; D Challine; D Valteau-Couanet; I Boland; A Deroussent; J Lemerle; A Gouyette; O Hartmann
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

  10 in total
  4 in total

1.  Computational approaches to find the active binding sites of biological targets against busulfan.

Authors:  T Karthick; Poonam Tandon
Journal:  J Mol Model       Date:  2016-05-30       Impact factor: 1.810

2.  Characterization of complexes between naftifine and cyclodextrins in solution and in the solid state.

Authors:  Maite Uzqueda; Carmen Martín; Arantza Zornoza; Miguel Sánchez; María Cristina Martínez-Ohárriz; Itziar Vélaz
Journal:  Pharm Res       Date:  2006-05-16       Impact factor: 4.200

Review 3.  The Relevance of Experimental Charge Density Analysis in Unraveling Noncovalent Interactions in Molecular Crystals.

Authors:  Sajesh P Thomas; Amol G Dikundwar; Sounak Sarkar; Mysore S Pavan; Rumpa Pal; Venkatesha R Hathwar; Tayur N Guru Row
Journal:  Molecules       Date:  2022-06-08       Impact factor: 4.927

Review 4.  Contributions of charge-density research to medicinal chemistry.

Authors:  Birger Dittrich; Chérif F Matta
Journal:  IUCrJ       Date:  2014-09-23       Impact factor: 4.769

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.